Stocksigma LogoStocksigma Logo

Evonile Pharma Approves Rights Issue of Up to ₹9,000 Million

Evonile Pharma Limited (formerly Novartis India Limited) approved the issuance of partly paid-up equity shares via a rights issue for up to ₹9,000 million

Evonile Pharma Approves Rights Issue of Up to ₹9,000 Million

Novartis India Ltd · Outcome · 05 Nov 2026, 12:45 am

Evonile Pharma Approves Rights Issue of Up to ₹9,000 Million Evonile Pharma Limited (formerly Novartis India Limited) approved the issuance of partly paid-up equity shares via a rights issue for up to ₹9,000 million. In its board meeting on 4th Nov'26, following prior approval on 8th Oct'26, the board cleared the payment schedule, proceed utilization, and the Letter of Offer for regulatory filing with BSE and SEBI. The Rights Issue Committee has been authorized to determine final terms, including the issue price, entitlement ratio, and record date.

Original exchange filing (PDF)

More announcements from Novartis India Ltd

All Novartis India Ltd announcements